论文部分内容阅读
目的对应用利拉鲁肽与二甲双胍联合对患有2型糖尿病的患者实施治疗的临床效果进行分析。方法 82例患有2型糖尿病的患者随机分为对照组和治疗组,每组41例。单纯应用二甲双胍对对照组患者实施治疗;采用利拉鲁肽与二甲双胍联合对治疗组患者实施治疗。结果治疗组患者2型糖尿病病情治疗总有效率90.3%明显优于对照组的68.3%,差异有统计学意义(P<0.05);血糖水平恢复正常时间(8.51±2.13)d和用药治疗总时间(13.75±2.08)d明显短于对照组(12.85±3.49)d和(18.04±3.16)d,差异有统计学意义(P<0.05)。结论应用利拉鲁肽与二甲双胍联合对患有2型糖尿病的患者实施治疗的临床效果非常明显。
Objective To analyze the clinical effect of liraglutide combined with metformin in the treatment of patients with type 2 diabetes. Methods 82 patients with type 2 diabetes were randomly divided into control group and treatment group, 41 cases in each group. The patients in the control group were treated with metformin alone and the patients in the treatment group were treated with liraglutide in combination with metformin. Results The total effective rate of type 2 diabetes mellitus was 90.3% in treatment group, which was significantly better than that of control group (68.3%) (P <0.05); the duration of return to normal blood glucose level (8.51 ± 2.13) (13.75 ± 2.08) d were significantly shorter than those in the control group (12.85 ± 3.49) d and (18.04 ± 3.16) d, respectively. The difference was statistically significant (P <0.05). Conclusion The combination of liraglutide and metformin in patients with type 2 diabetes, the clinical effect of treatment is very obvious.